Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Staphylococcal Vaccine”

30 trials

Showing 20 of 30 results

Testing effectiveness (Phase 2)Study completedNCT00572910
What this trial is testing

Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)

Who this might be right for
Staphylococcus Aureus Infection
Merck Sharp & Dohme LLC 206
Large-scale testing (Phase 3)Study completedNCT00211900
What this trial is testing

Evaluation of Manufacturing Lot of StaphVAX

Who this might be right for
Staphylococcal InfectionsChronic Kidney Failure
Nabi Biopharmaceuticals 65
Testing effectiveness (Phase 2)Ended earlyNCT02996448
What this trial is testing

Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome

Who this might be right for
Autosomal-dominant Hyper-IgE Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 3
Large-scale testing (Phase 3)Ended earlyNCT00130260
What this trial is testing

Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease

Who this might be right for
Staphylococcal InfectionsChronic Kidney Failure
Nabi Biopharmaceuticals 99
Early research (Phase 1)Study completedNCT00974935
What this trial is testing

Phase I STEBVax in Healthy Adults

Who this might be right for
Toxic Shock Syndrome Staphylococcal
National Institute of Allergy and Infectious Diseases (NIAID) 29
Large-scale testing (Phase 3)Ended earlyNCT00518687
What this trial is testing

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

Who this might be right for
Staphylococcus AureusBacteremiaMediastinitis
Merck Sharp & Dohme LLC 8,031
Testing effectiveness (Phase 2)Study completedNCT03455309
What this trial is testing

Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization

Who this might be right for
Staphylococcus Aureus
NovaDigm Therapeutics, Inc. 382
Early research (Phase 1)Study completedNCT01447407
What this trial is testing

Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine

Who this might be right for
Staphylococcal InfectionsYeast InfectionsCandidiasis
NovaDigm Therapeutics, Inc. 164
Large-scale testing (Phase 3)Study completedNCT00211965
What this trial is testing

StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery

Who this might be right for
Staphylococcal Infections
Nabi Biopharmaceuticals 67
Early research (Phase 1)Study completedNCT01643941
What this trial is testing

Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years

Who this might be right for
Staphylococcal Infections
Pfizer 284
Large-scale testing (Phase 3)Study completedNCT00211926
What this trial is testing

StaphVAX Immunogenicity in Orthopedic Implant Patients

Who this might be right for
Staphylococcal InfectionsJoint Prosthesis
Nabi Biopharmaceuticals 120
Early research (Phase 1)Study completedNCT00735839
What this trial is testing

V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)

Who this might be right for
Staphylococcal Infection
Merck Sharp & Dohme LLC 40
Early research (Phase 1)Study completedNCT02804711
What this trial is testing

A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults

Who this might be right for
Staphylococcus Aureus Infection
Jiangsu Province Centers for Disease Control and Prevention 144
Early research (Phase 1)Study completedNCT02364596
What this trial is testing

Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Who this might be right for
Staphylococcal Infections
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT00211991
What this trial is testing

Evaluation of Consistency of StaphVAX Manufacturing Lots

Who this might be right for
Staphylococcal Infections
Nabi Biopharmaceuticals 354
Early research (Phase 1)Study completedNCT01324440
What this trial is testing

Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002)

Who this might be right for
Staphylococcal Infections
Merck Sharp & Dohme LLC 64
Early research (Phase 1)Study completedNCT01273922
What this trial is testing

Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida

Who this might be right for
Staphylococcal InfectionsCandidiasis
NovaDigm Therapeutics, Inc. 40
Large-scale testing (Phase 3)Study completedNCT00071214
What this trial is testing

Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis

Who this might be right for
Staphylococcal InfectionsKidney Failure, Chronic
Nabi Biopharmaceuticals 3,600
Testing effectiveness (Phase 2)Study completedNCT04420221
What this trial is testing

Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)

Who this might be right for
Infections, Soft Tissue
GlaxoSmithKline 226
Early research (Phase 1)Study completedNCT01364571
What this trial is testing

Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Who this might be right for
Staphylococcal Infections
Pfizer 456
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation